
About Aerobiotix
Aerobiotix is a Healthcare company based in United States founded in 2013 by David Kirschman. UV-based disinfection systems are supplied for hospitals and facilities. Aerobiotix has raised $25 million across 1 funding round from investors including Vivo Capital and Asahi Kasei Ventures. Aerobiotix offers products and services including Illuvia Sense, AeroCure Vac, AeroCure 200, and GermZone Pro. Its focus areas include Life Sciences, Hospital Equipment, Hospital Infection Control and Air Sanitization. Its legal entity is AEROBIOTIX, LLC. Its competitors include R-Zero, Crystal IS and RayVio; 3 of its 3 listed competitors have raised funding.
Company details
Provider of UV-based disinfection systems for hospitals and other establishments. The products in Healthcare include Illuvia (air treatment systems), GermZone (upper room UV air Germicidal Systems), and GermVac (Negative pressure germicidal system). The Homecare product contains physician-designed laboratory-proven technology- Aerocure. The HVAC product is the Ultra V 250UV. The first product of the company was Tower One (T1) designed for air purification and disinfection system.
- Headquarters Ohio, United States
- Founders David Kirschman
- SectorsHealthcare
- Website aerobiotix.com
- Social LinkedIn X Facebook YouTube
- Legal Name Aerobiotix, Llc
- Total Equity Funding$25M (USD)
in 1 rounds
- Latest Funding Round$25M (USD), Series A
May 2021
- InvestorsVivo Capital
& 1 more
Products & Services of Aerobiotix
Aerobiotix offers a comprehensive portfolio of products and services, including Illuvia Sense, AeroCure Vac, AeroCure 200, and GermZone Pro.
Reduces infection risk in operating rooms using UV and HEPA filtration.
Decontaminates air by removing bioaerosols and surgical smoke.
Provides continuous air purification for healthcare environments.
Manages air quality to minimize microbial contamination.
Apps and channels of Aerobiotix
its YouTube channel Aerobiotix has 15 subscribers and 30 videos.
Videos from Aerobiotix
The most watched videos on Aerobiotix's YouTube channel, Aerobiotix (15 subscribers). Click a video to play it here.
More on Aerobiotix.
Funding Insights of Aerobiotix
Aerobiotix has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Series A round of $25 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25M
- Total Rounds 1
- Last Round Series A — $25M
- First Round $25M
(May 2021)
- Investors Count 2
All 1 funding rounds of Aerobiotix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2021 | $25M | Series A | – | Vivo Capital |
2 investors in total: 2 institutional.
Investors in Aerobiotix
Aerobiotix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Vivo Capital and Asahi Kasei Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and private equity firm | vivocapital.com | Palo Alto, United States | ||
Innovative global companies are supported through venture capital investments by Asahi Kasei Ventures. | 1922 | asahikaseiventures.com | Tokyo, Japan |
Investor details for Aerobiotix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aerobiotix
15 people are tracked at Aerobiotix (7 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
David Kirschman | Founder & Chief Scientific Officer | Leadership |
Michael L Schmitz | President / Chief Financial Officer | Leadership |
Michael Schmitz | CFO | Leadership |
Paul Ciovacco | Vice President Of Global Sales | Leadership |
Anthony Collias | General Manager EMEA | Leadership |
Julie Smith | Human Resources Director | Leadership |
David Letteri | Director of Quality Assurance/Regulatory Affairs | Leadership |
Thomas Gates, Jr. | Award Winning Area Sales Manager | Team |
Heidi Bates | Area Sales Manager | Team |
CJ Neumann | Area Sales Manager | Team |
Maria Revels | Manager, Sales and Marketing Support | Team |
Erick Convery | Area Sales Manager | Team |
Chris Remala | Regional Sales Manager | Team |
John Damer | Sales Agent | Team |
Jayne Rewucki | Area Sales Manager | Team |
Complete people profiles for Aerobiotix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aerobiotix
2 dated milestones of Aerobiotix across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Aerobiotix is founded.
- Funding First funding round of $25.0M.
Competitors of Aerobiotix
Aerobiotix has 3 listed competitors in our database, 3 of them funded. They include R-Zero, Crystal IS and RayVio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rzero.com | 2020 | San Francisco, United States | $162.4M | UV-C disinfection devices for hospital infection control are developed. | ||
| cisuvc.com | 1997 | Albany, United States | $15.23M | Ultraviolet light-emitting diodes are provided using aluminum nitride technology. | ||
| rayvio.com | 2012 | Hayward, United States | $35.3M | 9 | Provides educational content on online slots and gaming strategies. |
Detailed competitors of Aerobiotix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as Aerobiotix (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 8.15 B | 6,357 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aerobiotix
Complete news archive for Aerobiotix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aerobiotix
Aerobiotix was founded in 2013 and raised its 1st funding round 8 years after it was founded.
Aerobiotix is headquartered in United States. It is registered at Ohio, United States.
Aerobiotix is a funded company, having raised a total of $25M across 1 funding round to date. The company's 1st funding round was a Series A of $25M, raised on May 2021.
Provider of UV-based disinfection systems for hospitals and other establishments. The products in Healthcare include Illuvia (air treatment systems), GermZone (upper room UV air Germicidal Systems), and GermVac (Negative pressure germicidal system). The Homecare product contains physician-designed laboratory-proven technology- Aerocure. The HVAC product is the Ultra V 250UV. The first product of the company was Tower One (T1) designed for air purification and disinfection system.
Aerobiotix's top competitors include R-Zero, Crystal IS and RayVio.
Aerobiotix offers Illuvia Sense, AeroCure Vac, AeroCure 200, and GermZone Pro.
Aerobiotix has 2 investors. Key investors include Vivo Capital, and Asahi Kasei Ventures.
Aerobiotix operates through Aerobiotix, Llc.
